(firstQuint)Study of FLUTIFORM VS Seretide in Paediatric Subjects With Asthma.

 This is a study involving a 12 week treatment phase followed by a 6 month extension phase.

 During the treatment phase subjects receive FLUTIFORM(R) or Seretide(R).

 In the extension phase all subjects receive FLUTIFORM(R).

 Efficacy will be assessed by lung function tests and asthma symptoms, sleep disturbance.

 Safety will be assessed by adverse events, vital signs, lab tests and ECGs.

.

 Study of FLUTIFORM VS Seretide in Paediatric Subjects With Asthma@highlight

Study compares the efficacy and safety of FLUTIFORM(R) with Seretide(R) in the treatment of mild to moderate persistent asthma in pediatric subjects.

